23Andme Competitors

ME Stock  USD 1.92  0.10  5.49%   
23Andme Holding competes with IDEXX Laboratories, Twist Bioscience, Guardant Health, Agilent Technologies, and Thermo Fisher; as well as few others. The company is active under Biotechnology sector as part of Health Care industry. Analyzing 23Andme Holding competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of 23Andme Holding to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out 23Andme Holding Correlation with its peers.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of 23Andme Holding competition on your existing holdings.
  
The current year's Return On Tangible Assets is expected to grow to -2.13. The current year's Return On Capital Employed is expected to grow to -1.31. At present, 23Andme Holding's Net Tangible Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Current Assets Total is expected to grow to about 308.7 M, whereas Other Current Assets are forecasted to decline to about 9.5 M.
Specify up to 10 symbols:
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of 23Andme Holding's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.091.818.11
Details
Intrinsic
Valuation
LowRealHigh
1.6411.3517.65
Details
0 Analysts
Consensus
LowTargetHigh
36.4040.0044.40
Details
Earnings
Estimates (0)
LowProjected EPSHigh
0.000.000.00
Details

23Andme Holding Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between 23Andme Holding and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of 23Andme and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of 23Andme Holding does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
TMOA
ATWST
TMOTWST
TMOGH
GHIDXX
DHRA
  
High negative correlations   
DHRIDXX
DHRGH
BIOCDHR
BIOCTMO
BIOCA
BIOCDMTK

Risk-Adjusted Indicators

There is a big difference between 23Andme Stock performing well and 23Andme Holding Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze 23Andme Holding's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Cross Equities Net Income Analysis

Compare 23Andme Holding and related stocks such as IDEXX Laboratories, Twist Bioscience Corp, and Guardant Health Net Income Over Time
Select Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Shareholders Equity Per ShareDebt To Equity
Capex Per ShareGraham Net Net
Average ReceivablesRevenue Per Share
Interest Debt Per ShareDebt To Assets
Enterprise Value Over E B I T D AShort Term Coverage Ratios
Price Earnings RatioOperating Cycle
Price Book Value RatioPrice Earnings To Growth Ratio
Days Of Payables OutstandingDividend Payout Ratio
Price To Operating Cash Flows RatioPrice To Free Cash Flows Ratio
Pretax Profit MarginEbt Per Ebit
Operating Profit MarginEffective Tax Rate
Company Equity MultiplierLong Term Debt To Capitalization
Total Debt To CapitalizationReturn On Capital Employed
Debt Equity RatioEbit Per Revenue
Quick RatioDividend Paid And Capex Coverage Ratio
Net Income Per E B TCash Ratio
Cash Conversion CycleOperating Cash Flow Sales Ratio
Days Of Inventory OutstandingDays Of Sales Outstanding
Free Cash Flow Operating Cash Flow RatioCash Flow Coverage Ratios
Price To Book RatioFixed Asset Turnover
Capital Expenditure Coverage RatioPrice Cash Flow Ratio
Enterprise Value MultipleDebt Ratio
Cash Flow To Debt RatioPrice Sales Ratio
Return On AssetsAsset Turnover
Net Profit MarginGross Profit Margin
Price Fair ValueReturn On Equity
2010201120122013201420152016201720182019202020212022202320242025
IDXX3.2 M161.8 M178.3 M187.8 M181.9 M192.1 M222 M263.1 M377 M427.7 M581.8 M744.8 M679.1 M845 M887.9 M932.3 M
TWST(44.1 M)(44.1 M)(44.1 M)(44.1 M)(44.1 M)(44.1 M)(59.3 M)(71.2 M)(107.7 M)(139.9 M)(152.1 M)(217.9 M)(204.6 M)(208.7 M)(187.9 M)(197.2 M)
GH(46.1 M)(46.1 M)(46.1 M)(46.1 M)(46.1 M)(46.1 M)(46.1 M)(83.2 M)(85.1 M)(67.9 M)(246.3 M)(384.8 M)(654.6 M)(479.4 M)(436.4 M)(458.2 M)
A257 M1.2 B724 M497 M398 M460 M684 M316 M1.1 B719 M1.2 B1.3 B1.2 B1.3 B1.5 B1.6 B
TMO9.6 M1.3 B1.2 B1.3 B1.9 BBB2.2 B2.9 B3.7 B6.4 B7.7 BBB6.3 B6.7 B
DHR5.6 M2.2 B2.4 B2.7 B2.6 B3.4 B2.6 B2.5 B2.7 BB3.6 B6.4 B7.2 B4.7 B3.9 B4.1 B
ILMN(5.5 M)86.6 M151.3 M125.3 M353.4 M461.6 M462.6 M726 M826 MB656 M762 M(4.4 B)(1.2 B)(1.2 B)(1.2 B)
WATM433 M461.4 M450 M431.6 M469.1 M521.5 M20.3 M593.8 M592.2 M521.6 M692.8 M707.8 M642.2 M637.8 M362.5 M

23Andme Holding and related stocks such as IDEXX Laboratories, Twist Bioscience Corp, and Guardant Health Net Income description

Net income is one of the most important fundamental items in finance. It plays a large role in 23Andme Holding financial statement analysis. It represents the amount of money remaining after all of 23Andme Holding Co operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.

23Andme Holding Competitive Analysis

The better you understand 23Andme Holding competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, 23Andme Holding's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across 23Andme Holding's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
ME IDXX TWST GH A TMO DHR ILMN WAT
 5.49 
 1.92 
23Andme
 2.22 
 415.30 
IDEXX
 2.15 
 39.96 
Twist
 5.54 
 42.89 
Guardant
 3.28 
 121.18 
Agilent
 2.67 
 522.05 
Thermo
 3.26 
 210.74 
Danaher
 1.84 
 85.60 
Illumina
 3.49 
 377.15 
Waters
Market Volatility
(90 Days Market Risk)
Market Performance
(90 Days Performance)
Odds of Financial Distress
(Probability Of Bankruptcy)
Current Valuation
(Equity Enterprise Value)
Buy or Sell Advice
(Average Analysts Consensus)
Trade Advice
(90 Days Macroaxis Advice)
Current Ratio
Net Asset
Profit Margin
EBITDA
Operating Margin
Current Valuation
Price To Book
Retained Earnings
Current Asset
Five Year Return
Beta
Number Of Employees
Shares Outstanding
Cash Flow From Operations
Annual Yield
Total Debt
Return On Equity
Z Score
Return On Asset
Number Of Shares Shorted
Book Value Per Share
Current Liabilities
Total Asset
Debt To Equity
Short Ratio
Target Price
Last Dividend Paid
Shares Owned By Institutions
Market Capitalization
Price To Earning
Price To Earnings To Growth
Price To Sales
Net Income
Earnings Per Share
Shares Owned By Insiders
Revenue
Working Capital
Cash And Equivalents
Cash Per Share
Gross Profit
Day Typical Price
Accumulation Distribution
Daily Balance Of Power
Period Momentum Indicator
Rate Of Daily Change
Day Median Price
Price Action Indicator
Coefficient Of Variation
Mean Deviation
Jensen Alpha
Total Risk Alpha
Sortino Ratio
Downside Variance
Standard Deviation
Kurtosis
Potential Upside
Treynor Ratio
Maximum Drawdown
Variance
Market Risk Adjusted Performance
Risk Adjusted Performance
Skewness
Semi Deviation
Information Ratio
Value At Risk
Expected Short fall
Downside Deviation
Semi Variance

23Andme Holding Competition Performance Charts

Five steps to successful analysis of 23Andme Holding Competition

23Andme Holding's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by 23Andme Holding in relation to its competition. 23Andme Holding's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of 23Andme Holding in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact 23Andme Holding's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to 23Andme Holding, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your 23Andme Holding position

In addition to having 23Andme Holding in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Treasury ETFs Thematic Idea Now

Treasury ETFs
Treasury ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Treasury ETFs theme has 124 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Treasury ETFs Theme or any other thematic opportunities.
View All  Next Launch
Check out 23Andme Holding Correlation with its peers.
You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of 23Andme Holding. If investors know 23Andme will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about 23Andme Holding listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(17.39)
Revenue Per Share
8.269
Quarterly Revenue Growth
0.347
Return On Assets
(0.33)
Return On Equity
(1.94)
The market value of 23Andme Holding is measured differently than its book value, which is the value of 23Andme that is recorded on the company's balance sheet. Investors also form their own opinion of 23Andme Holding's value that differs from its market value or its book value, called intrinsic value, which is 23Andme Holding's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because 23Andme Holding's market value can be influenced by many factors that don't directly affect 23Andme Holding's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between 23Andme Holding's value and its price as these two are different measures arrived at by different means. Investors typically determine if 23Andme Holding is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, 23Andme Holding's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.